Investigating LGALS3BP/90 K glycoprotein in the cerebrospinal fluid of patients with neurological diseases
Autor(a) principal: | |
---|---|
Data de Publicação: | 2020 |
Outros Autores: | , , , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
Texto Completo: | http://hdl.handle.net/10451/49899 |
Resumo: | © The Author(s) 2020. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
id |
RCAP_e88263b5a5255efd98c6d1cfe815deb1 |
---|---|
oai_identifier_str |
oai:repositorio.ul.pt:10451/49899 |
network_acronym_str |
RCAP |
network_name_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository_id_str |
7160 |
spelling |
Investigating LGALS3BP/90 K glycoprotein in the cerebrospinal fluid of patients with neurological diseases© The Author(s) 2020. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.Galectin-3 binding protein (LGALS3BP or 90 K) is a secreted glycoprotein found in human body fluids. Deregulated levels were observed in cancer and infection and its study in neurological diseases is more recent. Here, we have investigated 90 K from human cerebrospinal fluid (CSF) of patients with amyotrophic lateral sclerosis (ALS, n = 35) and other neurological diseases (n = 23). CSF was fractionated by ultrafiltration/size-exclusion chromatography (SEC) and eluted fractions were analysed by complementary techniques including immunoblotting, electron microscopy and nano-liquid chromatography-tandem mass spectrometry. A fraction of 90 K appeared as nanoparticles of irregular shape with heterogeneous dimensions of 15-60 nm that co-eluted with extracellular vesicles in SEC. Median levels of 90 K quantified by ELISA were not different between ALS patients (215.8 ng/ml) and controls (213.3 ng/ml) in contrast with the benchmark biomarker for ALS phosphoneurofilament heavy chain (1750 and 345 pg/ml, respectively). A multiregression model supported age is the only independent predictor of 90 K level in both groups (p < 0.05). Significant correlation was found between 90 K levels and age for the ALS group (r = 0.366, p = 0.031) and for all subjects (r = 0.392, p = 0.003). In conclusion, this study unveils the presence of 90 K-containing nanoparticles in human CSF and opens novel perspectives to further investigate 90 K as potential aging marker.This work was supported by Euronanomed 2 ERA-NET project GlioEx (ENMed/0001/2013), Fundação para a Ciência e a Tecnologia (FCT), Portugal; iNOVA4Health Research Unit (LISBOA-01–0145-FEDER-007344), which is cofunded by FCT/Ministério da Ciência e do Ensino Superior, through national funds; and by FEDER under the PT2020 Partnership Agreement.Springer NatureRepositório da Universidade de LisboaCosta, JúliaPronto Laborinho, Ana CatarinaPinto, SusanaGromicho, MartaBonucci, SaraTranfield, ErinCorreia, CatarinaAlexandre, Bruno M.Carvalho, Mamede2021-10-15T13:10:47Z20202020-01-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/10451/49899engSci Rep. 2020 Mar 27;10(1):564910.1038/s41598-020-62592-w2045-2322info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2023-11-08T16:53:51Zoai:repositorio.ul.pt:10451/49899Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T22:01:25.488525Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse |
dc.title.none.fl_str_mv |
Investigating LGALS3BP/90 K glycoprotein in the cerebrospinal fluid of patients with neurological diseases |
title |
Investigating LGALS3BP/90 K glycoprotein in the cerebrospinal fluid of patients with neurological diseases |
spellingShingle |
Investigating LGALS3BP/90 K glycoprotein in the cerebrospinal fluid of patients with neurological diseases Costa, Júlia |
title_short |
Investigating LGALS3BP/90 K glycoprotein in the cerebrospinal fluid of patients with neurological diseases |
title_full |
Investigating LGALS3BP/90 K glycoprotein in the cerebrospinal fluid of patients with neurological diseases |
title_fullStr |
Investigating LGALS3BP/90 K glycoprotein in the cerebrospinal fluid of patients with neurological diseases |
title_full_unstemmed |
Investigating LGALS3BP/90 K glycoprotein in the cerebrospinal fluid of patients with neurological diseases |
title_sort |
Investigating LGALS3BP/90 K glycoprotein in the cerebrospinal fluid of patients with neurological diseases |
author |
Costa, Júlia |
author_facet |
Costa, Júlia Pronto Laborinho, Ana Catarina Pinto, Susana Gromicho, Marta Bonucci, Sara Tranfield, Erin Correia, Catarina Alexandre, Bruno M. Carvalho, Mamede |
author_role |
author |
author2 |
Pronto Laborinho, Ana Catarina Pinto, Susana Gromicho, Marta Bonucci, Sara Tranfield, Erin Correia, Catarina Alexandre, Bruno M. Carvalho, Mamede |
author2_role |
author author author author author author author author |
dc.contributor.none.fl_str_mv |
Repositório da Universidade de Lisboa |
dc.contributor.author.fl_str_mv |
Costa, Júlia Pronto Laborinho, Ana Catarina Pinto, Susana Gromicho, Marta Bonucci, Sara Tranfield, Erin Correia, Catarina Alexandre, Bruno M. Carvalho, Mamede |
description |
© The Author(s) 2020. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
publishDate |
2020 |
dc.date.none.fl_str_mv |
2020 2020-01-01T00:00:00Z 2021-10-15T13:10:47Z |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://hdl.handle.net/10451/49899 |
url |
http://hdl.handle.net/10451/49899 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
Sci Rep. 2020 Mar 27;10(1):5649 10.1038/s41598-020-62592-w 2045-2322 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Springer Nature |
publisher.none.fl_str_mv |
Springer Nature |
dc.source.none.fl_str_mv |
reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação instacron:RCAAP |
instname_str |
Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
instacron_str |
RCAAP |
institution |
RCAAP |
reponame_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
collection |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository.name.fl_str_mv |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
repository.mail.fl_str_mv |
|
_version_ |
1799134562685550592 |